Year: 2021

Apranga Group plans to reach EUR 290 million turnover (including VAT) in 2022, or by 28% higher than expected the year 2021 turnover. In 2022 Apranga Group plans to renovate or open 6-10 stores. The net investment is planned to be about EUR 2-5 million. Rimantas PerveneckasApranga Group General Manager+370 5 2390801

Life Cycle Assessment to analyse Weebit’s ReRAM carbon footprint compared to other Non-Volatile Memory technologies HOD HASHARON, Israel, Dec. 09, 2021 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT), a leading developer of next-generation memory technologies for the global semiconductor industry, and CEA-Leti, a leading nanotechnology research institute, are undertaking an environmental initiative that will analyse the environmental impact of Weebit’s Resistive Random-Access Memory (ReRAM) technology compared to other non-volatile memory (NVM) technologies. The Life Cycle Assessment (LCA) will estimate the contribution of Weebit’s NVM technology to climate change by quantifying its environmental impact. It will focus on total greenhouse gas (GHG) emissions associated with the uses of mineral, fossil and water resources, energy...

BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the upcoming departure of Pat Horn, M.D., Ph.D., Chief Medical Officer, who will be leaving at the end of the year after almost three and a half years with the Company. Jan Mattsson, Ph.D., Chief Scientific Officer and co-founder of Albireo, will be taking over as the interim head of R&D, leading research and development of early and late-stage assets and programs. As one of the co-founders of the Company with deep experience in drug development and approvals, Dr. Mattsson is primed to lead the R&D organization with his institutional knowledge, vision for the pipeline and products, and ability to deliver against corporate objectives. “Our company has made significant...

It will be among the first large-scale datacenters of its type in North America SALT LAKE CITY, Dec. 09, 2021 (GLOBE NEWSWIRE) — CleanSpark, Inc. (Nasdaq: CLSK) (the “Company” or “CleanSpark”), a sustainable bitcoin mining and energy technology company, today announced purchase of immersion cooling infrastructure for its Norcross bitcoin mining facility. Phased installation starts immediately, with the first 8 MW expected to go live in February. The new data center’s immersion cooling technology is expected to increase bitcoin mining efficiency by 20% or more, according to industry standards and the manufacturer. It is also expected to reduce operational expenses, enhancing CleanSpark’s competitive advantage that comes from the Company’s background in energy technology. ————————-Highlights...

CHARLOTTE, N.C., Dec. 09, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) announced today that the newly minted Humanity Wealth Advisors has joined LPL Financial’s broker-dealer, hybrid registered investment advisor (RIA) and custodial platforms, aligned with The Financial Services Network, an existing LPL large enterprise. The Humanity team reported having served approximately $250 million in advisory and brokerage assets*. They join from Wells Fargo Advisors. Founder Harry Sherdil and associate advisor Nestor Belmonte have worked together for 18 years from offices in Newark and San Ramone, Calif., mostly in the banking and wirehouse sector. The transition to independence represents the culmination of a long journey for Sherdil, who emigrated from India in 1990. He stated, “I come from a humble background. My mother had...

NEW YORK and VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, presented clinical results from its lead clinical candidate Bria-IMT™ in a poster session held on December 8, 2021 during the 2021 San Antonio Breast Cancer Symposium® (SABCS) (the “Poster”). The Poster submission was accepted by SABCS on September 15, 2021 and summarized the previously-disclosed Phase I/IIa clinical and pathological data from the clinical studies of the Bria-IMT™ regimen alone (the monotherapy studies) and the ongoing Phase I/IIa clinical study of Bria-IMT™ in combination with immune checkpoint inhibitors, including pembrolizumab...

NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) — WisdomTree (NASDAQ: WETF), an exchange-traded product (“ETP”) sponsor and asset manager, today announced forward share splits on the WisdomTree U.S. Total Dividend Fund (DTD) and the WisdomTree U.S. LargeCap Dividend Fund (DLN). Forward splits increase the number of shares outstanding and decrease the price per share. The splits will not change the total value of a shareholder’s investment. The stock splits will apply to shareholders of record as of the close of the markets on December 20, 2021, payable after the close of the markets on December 22, 2021. Shares will trade at their post-split price on December 23, 2021.Ticker Fund Name NAV per Share (as of 12/8/2021) Split RatioDTD WisdomTree U.S. Total Dividend Fund $125.96 2:1DLN WisdomTree U.S. LargeCap Dividend Fund $128.14 2:1The...

Scilex Holding Company, a commercial-stage, non-opioid biopharmaceutical pain management company, announces highly significant positive top-line results from its Phase 3 SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R Program for its novel, non-opioid, corticosteroid formulation, injectable dexamethasone sodium phosphate viscous gel product for the treatment of lumbosacral radicular pain (sciatica).   SP-102 (SEMDEXA™) has received Fast Track status from the FDA. The C.L.E.A.R. Program trial has met the primary efficacy and key secondary efficacy endpoints with highly statistical significance:For the primary endpoint of change in average daily pain (as measured by the Numeric Pain Rating Scale) in the affected leg over 4 weeks following the initial injection the LS Mean (SE) group difference of -1.08 (0.17) compared to placebo with a p-value...

SAN FRANCISCO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today released the “November 2021 Workplace Learning Skills Index,” which identifies the most in-demand skills consumed by organizations globally in November. With access to workplace learning activity generated by learners on Udemy’s enterprise learning solution, Udemy Business, Udemy research can help leaders and employees alike identify skills as they gain momentum, and upskill with timely courses needed to stay ahead of the curve. “I believe we’re moving into the ‘Great Optimization,’ a time when the value of every employee is truly understood,” said Cara Brennan Allamano, SVP of People, Places, and Learning at Udemy. “In this new era, I expect that leaders will be clamoring to find ways to optimize...